text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "cord%2Fcd133.arpe"

Did you mean: cord%2Fcd133.are?
29 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 2 Million
    Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 2 Million

     Bone Marrow CD34+ Cells, ≥2 million cells, cryopreserved, positively selected

    Catalog #: 2M-101D
    Sales unit: each
    Compare
    EA
  • Human Bone Marrow MNCs, Cryopreserved, 5 Million
    Human Bone Marrow MNCs, Cryopreserved, 5 Million

    Cryopreserved ampule of Human Bone Marrow Mononuclear Cells containing ≥5 million cells

    Catalog #: 2S-101D
    Sales unit: each
    Compare
    EA
  • Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 100,000
    Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 100,000

    Bone Marrow CD34+ Cells, 100,000 cells, cryopreserved, positively selected

    Catalog #: 2M-101
    Sales unit: each
    Compare
    EA
  • Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 1 Million
    Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 1 Million
    Bone Marrow CD34+ Cells, 1 Million, Cryopreserved, Positively Selected
    Catalog #: 2M-101C
    Sales unit: each
    Compare
    EA
  • Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 500,000
    Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 500,000

    Bone Marrow CD34 Cells+, 500,000 cells, cryopreserved, isolated from mononuclear cells using positive immunomagnetic selection

    Catalog #: 2M-101B
    Sales unit: each
    Compare
    EA
  • Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 300,000
    Human Bone Marrow CD34+ Progenitor Cells, Cryopreserved, 300,000

    Bone Marrow CD34+ Cells, 300,000 cells, cryopreserved, positively selected

    Catalog #: 2M-101A
    Sales unit: each
    Compare
    EA
  • SF Cell Line 4D-Nucleofector™ X Kit S
    SF Cell Line 4D-Nucleofector™ X Kit S

    For efficient transfection of difficult-to-transfect cell lines, e.g. K-562, Neuro-2A or RAW264.7, in the 4D-NucleofectorTM X Unit (20 µL format).

     

    Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.

    Catalog #: V4XC-2032
    Sales unit: kit
    Compare
    SA
  • SF Cell Line 4D-Nucleofector™ X Kit L
    SF Cell Line 4D-Nucleofector™ X Kit L
    For efficient transfection of difficult-to-transfect cell lines, e.g. K-562, Neuro-2A or RAW264.7, in the 4D-NucleofectorTM X Unit (100 µL format).
    Catalog #: V4XC-2012
    Sales unit: kit
    Compare
    SA
  • SF Cell Line 4D-Nucleofector™ X Kit L
    SF Cell Line 4D-Nucleofector™ X Kit L
    For efficient transfection of difficult-to-transfect cell lines, e.g. K-562, Neuro-2A or RAW264.7, in the 4D-NucleofectorTM X Unit (100 µL format).
    Catalog #: V4XC-2024
    Sales unit: kit
    Compare
    SA
  • 1
  • 2(current)

You searched for "X-VIVO"

755 Documents found
  • References - X-Vivo™
    Overview of relevant references
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Serum-free Media FFM Part Codes
    2019 change of all RUO Media to FFM production overview of RUO and new FFM part codes (X-VIVO not included)
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content.
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • TheraPEAK® T-VIVO® Cell Culture Medium – Overview
    View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
  • Terms and Conditions TheraPEAK T-VIVO Sample Request Program
  • 4D-Nucleofector® LV Unit for Large-scale Transfection
    Efficient, closed and scalable transfection for ex vivo cell and gene therapy applications
  • Instructions for Use - TheraPEAK® T-VIVO® Cell Culture Medium
    Instructions for how to use the TheraPEAK® T-VIVO® Cell Culture Media Series
  • Developing Patient-specific Cell Therapy Manufacturing Processes
    Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
  • Modeling a 3D respiratory model with the Quasi Vivo® QV600 Fluidic Cell Culture System
    In this Technical Note, we provide detailed information of how the Quasi Vivo® QV600 System was set up for the ALI culture of normal human bronchial or small airway epithelial (NHBE, SAE) cells.
  • Non-Viral Methods for Ex vivo Cell and Gene Therapy – Is the Future Non-viral?
    Learn from this interview about the types and benefits of non-viral methods for ex vivo cell and gene therapy as well as the readiness of electroporation-based technologies for use in GMP manufacturing.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • Clonetics™ and Poietics™ Disease Cells
    In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
  • Fast-Track Development of an In Vitro 3D Lung/Immune Cell Model Using the Quasi Vivo® System
  • A Novel in vitro Liver Cell Culture Flow System Allowing Long-term Metabolism and Hepatotoxicity Studies
    Lonza Scientific poster. Here we present an alternative in vitro model that is based on the long-term culture of PHH in the Quasi Vivo® QV900 flow system.
  • 1(current)
  • 2
  • 3